&w=3840&q=100)
Asian Paints shares rise 3% after large deal in pre-open; all details here
Asian Paints share price gained 2.5 per cent in trade on Thursday, June 12, 2025, logging an intraday high at ₹2,263.95 per share on BSE. The buying on the counter came after a large deal took place in the pre-opening session.
At 9:57 AM, Asian Paints shares were trading 2.06 per cent lower at ₹2,254 per share on the BSE. In comparison, the BSE Sensex was down 0.12 per cent at 82,412.64. The company's market capitalisation stood at ₹2,16,203.18 crore. Its 52-week high was at ₹3,394 per share and 52-week low was at ₹2,125 per share.
Asian Paints block deal details
According to data available on Bloomberg, 35 million shares changed hands in a single block deal on NSE in the market pre-opening session. This accounted for 3.65 per cent of equity. Block changed hands at ₹2,201 per share against last close of ₹2,208.8 per share. Buyers and sellers of the deals were not disclosed.
As of quarter ending March 2025, India's mutual funds have a 5.67 per cent stake in Asian Paints at the end of the March quarter, with ICICI Prudential Mutual Fund holding at 1.24 per cent and SBI Mutual Fund at 1.51 per cent.
Besides, Life Insurance Corporation of India holds 8.29 per cent stake in the company.
The complaint was filed by Aditya Birla group in November last year, alleging that Asian Paints, which is the market leader with 53 per cent market share, had indulged in anti-competitive conduct and exclusionary practices.
The allegations included restricting dealers from doing business with Grasim's Birla Opus. Grasim is a flagship company of the Aditya Birla group. It was also alleged that Asian Paints had put pressure on raw material suppliers to deny (supplies) or price-discriminate against Birla Opus.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Business Standard
40 minutes ago
- Business Standard
Syngene's Bengaluru-based facility gets 'NAi' status from US FDA
Syngene International said that the United States Food and Drug Administration (US FDA) conducted a good clinical practices (GCP) compliance inspection of the company's facility located at Semicon Park, Bengaluru, from 09 to 13 of June 2025. The inspection concluded successfully, with the facility found to be in compliance with the required regulations. The inspection resulted in zero observations and no Form 483 was issued. The inspection has been classified as no action indicated (NAI). The company remains commitment to high operating standards and rigorous compliance with global regulatory requirements across all its operations, Syngene said in a statement. Syngene International is an integrated research, development, and manufacturing services company serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. On a consolidated basis, net profit of Syngene International declined 2.81% to Rs 183.30 crore while net sales rose 11.03% to Rs 1018 crore in Q4 March 2025 over Q4 March 2024. The scrip had lost 1.57% to end at Rs 652.50 on the BSE on Friday.
Business Standard
an hour ago
- Business Standard
NATCO Pharma's Hyderabad-based plant gets 'one' Form 483 observation post US FDA audit
NATCO Pharma said that the U.S. Food and Drug Administration (FDA) had conducted an inspection at the API manufacturing plant located in Mekaguda, Hyderabad, India, which was conducted from 09 to 13 of June 2025. On conclusion of the inspection, the company received one observation in the Form-483. The company believes that the observation is procedural in nature. The company is confident to address this observation comprehensively. NATCO Pharma, headquartered at Hyderabad, India, develops, manufactures and distributes generic and branded pharmaceuticals, specialty pharmaceuticals, active pharmaceutical ingredients and crop protection products. The companys consolidated net profit increased 5.3% to Rs 406.60 crore on 14.3% jump in revenue from operations to Rs 1,221 crore in Q4 FY25 over Q4 FY24. The scrip had declined 1.26% to end at Rs 912.55 on the BSE on Friday.
Economic Times
4 hours ago
- Economic Times
SpiceJet Q4 Results: PAT jumps 173% YoY to highest-ever quarterly profit of Rs 325 crore
Live Events (You can now subscribe to our (You can now subscribe to our ETMarkets WhatsApp channel Budget carrier Spicejet on Saturday reported that its March quarter standalone profit after tax surged 173% year-on-year (YoY) to Rs 324.87 crore. For the Gurugram-based airline, this is the highest ever quarterly profit and second consecutive profitable the revenue from operations for the reporting quarter declined 16% YoY to Rs 1,446.37 crore from Rs 1,719.3 crore in Q4 FY24, SpiceJet the entire FY25, SpiceJet posted full‐year net profit of Rs 48 crore, the first in seven years, underscoring the success of its financial and operational turnaround strategy. In FY24, the airline had reported a loss of Rs 404 that the growth is led by improved yields, sustaining high load factors, and cost optimization, SpiceJet said the passenger load factor stood at 88.1%, highlighting strong RASK improved by 3.4% YoY, and the airline has achieved a positive net worth of Rs 683 crore at the end of the Promoter Group completed an equity infusion of Rs 500 crore, including the final tranche of Rs 294.09 crore in Q4 FY25, underscoring its strong confidence in the company's long‐term vision and potential.'SpiceJet has delivered a strong set of results, marking a significant turnaround in our operational and financial performance. With a strengthened balance sheet, renewed investor trust and continued network expansion, SpiceJet is well‐positioned for sustainable growth," SpiceJet Chairman and Managing Director Ajay Singh the revival of SpiceJet's grounded fleet has taken longer than anticipated due to complex global supply chain and engine overhaul challenges, he said the momentum is now clearly building."Our partnerships with world‐class OEMs and MROs like StandardAero andCarlyle Aviation are bearing fruit, and engine overhauls are underway. With overhauled engines now returning, we expect a steady ramp‐up in operational capacity in the weeks ahead," Singh of the announcement of results on Saturday, SpiceJet shares ended Friday's session 2% lower at Rs 43.81 on BSE.
